Figure 3

Impacts of iguratimod (IGU) on inflammatory factor levels (IL-6, TNF-α, IL-17, and IL-1β) in non-obese diabetic (NOD) mice. Model vs. normal, ^#p < 0.05, ^##p < 0.01. IGU 10 mg/kg and IGU 30 mg/kg vs. model, *p < 0.05, **p < 0.01. IGU 30 mg/kg vs. IGU 10 mg/kg, ^△p < 0.05, ^△△p < 0.01.